WHO recommends Pfizer’s Paxlovid for wide geographical distribution
Pfizer’s oral antiviral drug (a combination of Nirmatrelvir and Ritonavir tablets) is strongly recommended for patients with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID-19 drug
Britain widens access to Pfizer’s COVID anti-viral drug through trial
Paxlovid, a combination of Pfizer's new pill with an older anti-viral ritonavir, was made available to thousands of people with…
Study finds Neem tree-based drugs may help fight against COVID
The study, led by a team from the Indian Institute of Science Education and Research, Kolkata, shows that components of Neem bark…
WHO updates its treatment guidelines to include molnupiravir
The recommendation is based on new data from six randomised controlled trials involving 4,796 patients. This is the largest…
Movfor phase-III trials show positive results: Hetero
Early viral clearance (negative RT-PCR) and significant clinical improvement were observed within five days of administering the…
Five-day course of Molnupiravir effective and safe for non-pregnant and unvaccinated COVID-19 adult…
The study has been conducted jointly by Fortis C-DOC, G D Hospital and Diabetes Institute, Jawaharlal Nehru Medical College and…
US FDA authorises Eli Lilly’s COVID-19 antibody drug
The FDA authorised bebtelovimab for emergency use in patients with mild-to-moderate COVID-19 who are at high risk of progression…
China approves use of Pfizer’s COVID drug Paxlovid
It is not immediately clear if China is already in talks with Pfizer to procure the pill
New antiviral drug combo highly effective against coronavirus: Study
The research, published recently in the journal Nature, suggests that these drugs are more potent when used in combination than…
Pfizer shares in-vitro efficacy of novel COVID-19 oral treatment against Omicron
The in-vitro studies suggest that Paxlovid has the potential to maintain plasma concentrations many-fold times higher than the…